Filana Therapeutics
FLNA
33 hedge funds and large institutions have $9.91M invested in Filana Therapeutics in 2017 Q2 according to their latest regulatory filings, with 4 funds opening new positions, 15 increasing their positions, 10 reducing their positions, and 10 closing their positions.
50% more repeat investments, than reductions
Existing positions increased: 15 | Existing positions reduced: 10
31.38% more ownership
Funds ownership: 5.3% → 36.68% (+31%)
15% less funds holding
Funds holding: 39 → 33 (-6)
35% less capital invested
Capital invested by funds: $15.3M → $9.91M (-$5.36M)
60% less first-time investments, than exits
New positions opened: 4 | Existing positions closed: 10
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Dimensional Fund Advisors
Austin,
Texas
|
+$283K |
| 2 |
Bank of New York Mellon
New York
|
+$81.3K |
| 3 |
ARTA
A.R.T. Advisors
New York
|
+$55.7K |
| 4 |
VKH
Virtu KCG Holdings
New York
|
+$43.3K |
| 5 |
GS
Gagnon Securities
New York
|
+$41.6K |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Vanguard Group
Malvern,
Pennsylvania
|
-$203K |
| 2 |
BlackRock
New York
|
-$150K |
| 3 |
Renaissance Technologies
New York
|
-$128K |
| 4 |
BCM
Bridgeway Capital Management
Houston,
Texas
|
-$55.9K |
| 5 |
TA
Teton Advisors
Rye,
New York
|
-$40K |
FLNA Hedge Fund Activity: Q2 2017 in Review
33 of the 4,011 institutional investors tracked by Wall St. Rank reported a position in Filana Therapeutics (FLNA) for Q2 2017, worth a combined $9.91M — down 35% from $15.3M a quarter earlier.
Sellers outnumbered buyers: 10 funds closed out of FLNA and 4 opened new positions — a net loss of 6 holders — while 10 trimmed existing stakes and 15 added.
The largest buyer was Dimensional Fund Advisors, opening a new position worth an estimated $283K. The largest seller was Vanguard Group, cutting an estimated $203K.
- 33 institutional investors held Filana Therapeutics (FLNA) as of Q2 2017, down from 39 in Q1 2017.
- Funds reported $9.91M of Filana Therapeutics stock for Q2 2017, down 35% quarter-over-quarter.
- 4 funds opened new Filana Therapeutics positions in Q2 2017 and 10 closed out, a net change of -6 holders.
- The largest Filana Therapeutics buyer in Q2 2017 was Dimensional Fund Advisors, an estimated $283K added.
- The largest Filana Therapeutics seller in Q2 2017 was Vanguard Group, an estimated $203K sold.
Based on aggregated 13F filings for Q2 2017.